| Literature DB >> 27012365 |
Yong Zhang1, Makoto Toneri1,2, Huaiyu Ma1, Zhijian Yang1, Michael Bouvet2, Yusuke Goto3, Naohiko Seki4, Robert M Hoffman5,6.
Abstract
There are two major types of mouse xenograft models of cancer: subcutaneous implantation and orthotopic implantation. Subcutaneous transplant models are widely used with both cancer cell lines and human-tumor specimens. Recently, subcutaneous models of patient tumors, termed patient-derived xenographs (PDX) have become highly popular and have acquired such names as "Avatar" and "Xenopatients." However, such s.c. models rarely metastasize and are therefore not patient-like. In contrast, orthotopic models have the capability to metastasize. If intact fragments of tumor tissue are implanted by surgical orthotopic implantation (SOI), the metastatic potential can match that of the donor patient. The present study images in real time, using green fluorescent protein (GFP) expression, the very different tumor behavior at the orthotopic and subcutaneous sites of human prostate cancer PC-3 in athymic nude mice. By day-2 after tumor implantation, the orthotopic tumor is already highly vascularized and the cancer cells have begun to migrate out of the tumor. In contrast, the subcutaneous tumor only begins to be vascularized by day-3 and cells do not migrate from the tumor. Angiogenesis is much more extensive in the orthotopic tumor throughout the 2-week observation period. The orthotopic PC-3-GFP tumor progresses very rapidly and distinct metastasis have appeared in lymph nodes by day-3 which rapidly appear in many areas of the abdominal cavity including portal lymph nodes by day-7. At day-14, no invasion or metastasis was observed with the s.c. tumor even when the animal was extensively explored. These results explain why orthotopic tumors mimimc clinical metastatic tumors in nude mice and why subcutaneous tumors do not. J. Cell. Biochem. 117: 2546-2551, 2016.Entities:
Keywords: ANGIOGENESIS; GFP IMAGING; INTRAVITAL; INVASION; METASTASIS; ORTHOTOPIC; PC-3; PROSTATE CANCER; SUBCUTANEOUS
Mesh:
Substances:
Year: 2016 PMID: 27012365 DOI: 10.1002/jcb.25547
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429